Abstract
Introduction
The etiopathogenesis of Insulin resistance is a field of extensive research. Insulin resistance attributed to both inherited and acquired factors. Mutations in several genes including insulin receptor substrate-1 (IRS-1) and glycogen synthase gene have been described. Gene mutations so far implicated collectively, however, explain only a small proportion (<5%) of all cases of insulin resistance which suggest that genetically determined insulin resistance is not a dominant cause for the development of type 2 diabetes 1 .
Results of impaired insulin signaling system in insulin resistance
Impaired insulin signaling results from mutations or post translational modifications of the insulin receptor itself or any of its downstream effector molecules 2 .
Evidence suggests that aggravated insulin resistance in T2DM is primarily of a post receptor nature 3 . Insulin receptor tyrosine kinase activity in patients with T2DM is significantly reduced 4 .
The insulin receptor signaling pathways
There are two major insulin signaling pathways are MAP kinase ( Figure I ) and PI3-K pathways ( Figure II) . The heterotetrameric insulin receptor with proteinprotein interaction domains involved in insulin signaling 2 . The insulin receptor (Fig I and II) is a transmembrane tyrosine kinase (tyr-kinase) which is widely expressed. It consists of two ligand binding a subunits and two tyr-kinase b subunits that are disulfide linked and form a2b2 heterotetrameric complex 3, 5 .
Binding of insulin in specific regions of the a subunit generates a signal across the plasma membrane that autophosphorylates the intracellular tyr-kinase domain of the b subunit. This autophosphorylation results in activation of the tyr-kinase activity of the receptor. The catalytic site of the tyr-kinase is occluded by the 'activation loop' in its inactive state which prevents access of ATP and various substrates. Autophosphorylation of tyrosine residues in the activation loop causes a conformational change that allows ATP and substrates to reach the catalytic site 6, 7 . 13 . These interactions need so broad discussion that is beyond the limit of present article. A separate review article is needed for this.
Environmental factors
Environmental factors implicated in the development of insulin resistance include: 1) aging, 2) dietary constituents, 3) level of physical inactivity, 4) pregnancy, 5) obesity and 6) hypertension and 7) smoking.
Aging: It is argued that insulin sensitivity decreases with age since (i) advancement of age showed association with changes in body composition, i.e. loss of muscle mass and increase in fat deposition which cause reduction of active metabolic tissue; ii) change in lifestyle (diet and physical activity); iii) neuro-hormonal variation; and iv) increased oxidative stress [14] [15] [16] [17] [18] [19] .
However, healthy centenarians found to have a preserved insulin action compared to aged subjects 19 , in healthy Europeans, age per se is not a significant cause of insulin resistance 15 . Age related deterioration in glycemic dysregulation suggested to be resulting from decrease in beta cell function without change in insulin sensitivity 20 .
Dietary constituents:
Dietary constituents are known to influence insulin sensitivity. Individuals often accustomed to diet rich in calorie. It is known that choice of food attributed to socio-cultural factors. In case of diet habit of rich food excess calorie is deposited as fat giving rise to chance of obesity. Diet containing high fat, low fibers and more refined carbohydrates tend to reduce insulin sensitivity 21 . It is not only calorie value of food counts rather dietary fibers and trace elements are also of great importance. Dietary fibers play important role in dynamics of absorption from the intestine. Trace elements play critical role as cofactors of different enzymes. So far magnesium and selenium found to have important influence on insulin sensitivity 22, 23 .
Exercise: Physical activity found to improve insulin sensitivity 24 . Short term low intensity exercise reduces insulin resistance without affecting BMI 25 although it does not affect insulin secretion. The underlying mechanism of exercise to reduce insulin resistance is yet to fully understood, however, it have been proposed that exercise causes increase in insulin induced glucose uptake and subsequently increased glycogen synthesis activity in skeletal muscle 1 . It was also suggested that exercise causes contraction-induced increase in GLUT-4 content in skeletal muscle. Acute exercise also enhances insulin stimulated GLUT-4 translocation [26] [27] [28] . Exercise also found to reduce triglyceride levels and improve insulin sensitivity. However, the effect of exercise on insulin sensitivity is transient and disappears after 17-19 days on discontinuation 29 .
Pregnancy: Women with pregnancy both obese and non-obese were reported to develop insulin resistance during third trimester 30 . The mechanism of development of this insulin insensitivity has, however, not yet fully elucidated. Although from metabolic point of view pregnancy was claimed to be a state of accelerated starvation 31 . In early part of gestation maternal fat deposition was reported and possibly owing to effects of lipolytic hormones e.g. human placental lactogen and human chorion gonadotropin 1 plasma free fatty acids level rise during later part of pregnancy and might be other plausible factors accentuating the insensitivity if insulin which are yet to be identified.
Obesity:
Obesity is reported to be one of the strongest predictors of low insulin sensitivity. For each kilogram of weight gain, the risk of diabetes increases between 4.5% and 9% 1, 32 . Insulin resistance increases with weight gain and decreases with weight loss; indicating insulin resistance related to obesity is a reversible condition. Causes of insulin resistance in obesity are not fully understood. It is hypothesized that the expanding adipose tissue of the obese individuals may produce compounds that are either released into the bloodstream and cause insulin resistance in remote targets (e.g. in skeletal muscle or liver), or in close vicinity of target organs acting through paracrine mechanisms 33 . Among these secreted compounds are: 1) Tumour necrosis factor alpha (TNF), 2) free fatty acids (FFA), 3) leptin, 4) resistin and 5) adiponectin.
TNFa-TNFa is over expressed in adipose tissue of obese insulin resistant rodents and humans, and has been shown to produce insulin resistance in isolated cell systems 34 . However, several others have suggested TNFa to be unlikely contributor in the development of insulin resistance associated with obesity 35, 36 . FFAsThere are many evidences which show that FFAs are an important link between obesity and insulin resistance 33, 37, 38 . Location of the FFAs induced defect may be either at the level of ISGU or glucose phosphorylation or an inhibition of carbohydrate oxidation 39, 37 .
Rates of ISGU, glycogen synthesis and glycolysis all were found to reduce in the presences of higher blood FFAs levels. Increasing plasma FFAs was associated with an acute increase in intramyocellular triglyceride (IMCL-TG) and 40% increase in insulin resistance. IMCL-TG is a metabolically active pool of fat consisting of small oil droplets located in close proximity to mitochondria providing fuel 1 .
Leptin -Leptin was identified 40 as an adipocyte derived hormone and found to reduce body weight via specific receptors in hypothalamic areas regulating energy expenditure and satiety. Leptin deficiency and receptor defects in rodents found to cause marked obesity as well as hyperinsulinaemia and hyperglycaemia. Number of studies has focused on the effects of leptin on insulin resistance and insulin secretion. Both inhibition and stimulation of insulin action have been shown by leptin in different cell systems. Therefore, the conclusion that leptin causes a defect in the insulin signaling chain or that it is capable of improving -cell dysfunction in human subjects cannot yet be made on the basis of these studies 41 .
Resistin -Resistin is a protein released from white adipose tissue of mice which can cause insulin resistance 42 . However, whether it plays a role in human physiology is still unclear.
Adiponectin -It is also a protein released from adipose tissue which has been reported to have potential role in the determination of insulin sensitivity. It is more strongly inversely related with intra abdominal than subcutaneous fat 43, 44 . Though some recent studies have shown that it was not BMI but the quantity of intraabdominal fat was strongly related to insulin sensitivity 45 .
Hypertension: Studies show that there is significant relationship between plasma insulin level and both diastolic and systolic blood pressure in both obese and non-obese subjects [46] [47] [48] .
Smoking:
Smoking is reported to reduce serum HDLCholesterol levels and increase serum triglyceride levels both of which causes diminution of insulin sensitivity. Moreover, a number of medications including corticosteroids 49 and growth hormone 50 have been shown to induce insulin resistance.
Conclusion
Insulin resistance is the result of interactions of genetic and acquired causes. Effective measures to ameliorate the common factors (Environmental factors in particular) may help prevent the possible chance of developing the insulin resistant and its related conditions and improve the situation apart from already established phenomena.
